These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21030232)

  • 21. Chronic obstructive pulmonary disease involves substantial health-care service and social benefit costs.
    Jensen MB; Fenger-Grøn M; Fonager K; Omland Ø; Vinding AL; Hansen JG
    Dan Med J; 2013 Jan; 60(1):A4557. PubMed ID: 23340185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers.
    Miravitlles M; Ferrer M; Pont A; Luis Viejo J; Fernando Masa J; Gabriel R; Jiménez-Ruiz CA; Villasante C; Fernández-Fau L; Sobradillo V
    Respir Med; 2005 Aug; 99(8):985-95. PubMed ID: 15950139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of smoking-related hyperhomocysteinemia on spirometric declines in chronic obstructive pulmonary disease in elderly Japanese.
    Kai S; Nomura A; Morishima Y; Ishii Y; Sakamoto T; Hegab AE; Sekizawa K
    Arch Gerontol Geriatr; 2006; 42(2):117-24. PubMed ID: 16125804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overlap syndrome of asthma and COPD predicts low quality of life.
    Kauppi P; Kupiainen H; Lindqvist A; Tammilehto L; Kilpeläinen M; Kinnula VL; Haahtela T; Laitinen T
    J Asthma; 2011 Apr; 48(3):279-85. PubMed ID: 21323613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of the COPD health care costs study. COPD in Germany--unrecognized and cost intensive].
    Krankenpfl J; 2003; 41(7-9):158-61. PubMed ID: 14705523
    [No Abstract]   [Full Text] [Related]  

  • 26. [Active tobacco smoking as determinant of costs of inpatient treatment of COPD exacerbations].
    Targowski T; Jahnz-Rózyk K; From S; Płusa T
    Przegl Lek; 2004; 61(10):1049-51. PubMed ID: 15794248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathomechanisms in chronic obstructive pulmonary disease (COPD)].
    Glaab T; Hohlfeld JM; Jörres RA; Krug N; Welte T
    Med Klin (Munich); 2006 Dec; 101(12):951-6. PubMed ID: 17171318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Farming and the prevalence of non-reversible airways obstruction: results from a population-based study.
    Lamprecht B; Schirnhofer L; Kaiser B; Studnicka M; Buist AS
    Am J Ind Med; 2007 Jun; 50(6):421-6. PubMed ID: 17497693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological dust exposure in the workplace is a risk factor for chronic obstructive pulmonary disease.
    Matheson MC; Benke G; Raven J; Sim MR; Kromhout H; Vermeulen R; Johns DP; Walters EH; Abramson MJ
    Thorax; 2005 Aug; 60(8):645-51. PubMed ID: 16061705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The relationship between bronchial hyperresponsiveness and chronic obstructive pulmonary disease].
    Li Q; Xie G; Cheng X
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Oct; 24(10):584-7. PubMed ID: 11770417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
    Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
    Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of COPD in Copenhagen.
    Fabricius P; Løkke A; Marott JL; Vestbo J; Lange P
    Respir Med; 2011 Mar; 105(3):410-7. PubMed ID: 20952174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma.
    Vozoris NT; Stanbrook MB
    Respir Med; 2011 Mar; 105(3):477-84. PubMed ID: 20850288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are patient characteristics helpful in recognizing mild COPD (GOLD I) in daily practice?
    Geijer RM; Sachs AP; Verheij TJ; Lammers JW; Salomé PL; Hoes AW
    Scand J Prim Health Care; 2006 Dec; 24(4):237-42. PubMed ID: 17118864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COPD 'diagnosis' based on spirometric reference equations.
    Olofson J; Bake B; Tengelin MN; Houltz B
    Clin Respir J; 2008 Oct; 2(4):214-9. PubMed ID: 20298337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of outpatients with COPD in daily practice: The E4 Spanish project.
    Viejo-Bañuelos JL; Pueyo-Bastida A; Fueyo-Rodríguez A
    Respir Med; 2006 Dec; 100(12):2137-43. PubMed ID: 16831541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decline in FEV1 related to genetic polymorphisms (+138insA/delA and Lys198Asn) of the endothelin-1 gene in COPD. A pilot study.
    Kaparianos A; Argyropoulou E; Efremidis G; Flordellis C; Spiropoulos K
    Eur Rev Med Pharmacol Sci; 2010 Aug; 14(8):705-19. PubMed ID: 20707291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.
    Decramer M; Gosselink R; Rutten-Van Mölken M; Buffels J; Van Schayck O; Gevenois PA; Pellegrino R; Derom E; De Backer W
    Thorax; 2005 Apr; 60(4):335-42. PubMed ID: 15790991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Are systematic consultation invitations and spirometry in general practice useful in the prevention of COPD among smokers?].
    Hansen KV; Dibbern H; Bentzon A
    Ugeskr Laeger; 2008 Dec; 170(50):4121-3. PubMed ID: 19091190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.